Lovaltech Overview

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $469K

  • Investors
  • 5

Lovaltech General Information

Description

Developer of an intranasal vaccine platform designed to prevent and reduce the transmission of respiratory infectious diseases through mucosal immunity. The company offers a muco-excipient platform combining recombinant antigens with nanocarrier-based delivery technology and supports proteins, mRNA, peptides, and viral vectors, enabling pharmaceutical companies and healthcare organizations to develop needle-free vaccines and enhance localised immune protection against infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 49 Boulevard Preuilly
  • 37000 Tours
  • France
+33 06
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • 49 Boulevard Preuilly
  • 37000 Tours
  • France
+33 06

Lovaltech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lovaltech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC 01-Jan-2026 $469K In Progress Clinical Trials - Phase 2
8. Equity Crowdfunding 01-Mar-2026 Announced Clinical Trials - Phase 2
7. Debt - General Announced Clinical Trials - Phase 1
6. Grant Completed Clinical Trials - Phase 1
5. Grant 31-Aug-2025 Completed Clinical Trials - Phase 1
4. Early Stage VC 01-Jun-2025 Completed Pre-Clinical Trials
3. Seed Round 23-Apr-2024 Completed Pre-Clinical Trials
2. Seed Round 31-May-2023 $1.63M $1.63M Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Lovaltech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lovaltech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lovaltech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpi (Boise) Venture Capital Minority
UI Investissement PE/Buyout Minority
Bpifrance Sovereign Wealth Fund Minority
Da Vinci Labs Accelerator/Incubator Minority
The Place by CCI 37 Accelerator/Incubator
To view Lovaltech’s complete investors history, request access »

Lovaltech FAQs

  • Where is Lovaltech headquartered?

    Lovaltech is headquartered in Tours, France.

  • What is the size of Lovaltech?

    Lovaltech has 6 total employees.

  • What industry is Lovaltech in?

    Lovaltech’s primary industry is Biotechnology.

  • Is Lovaltech a private or public company?

    Lovaltech is a Private company.

  • What is Lovaltech’s current revenue?

    The current revenue for Lovaltech is .

  • How much funding has Lovaltech raised over time?

    Lovaltech has raised $9.8M.

  • Who are Lovaltech’s investors?

    Bpi (Boise), UI Investissement, Bpifrance, Da Vinci Labs, and The Place by CCI 37 have invested in Lovaltech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process